Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED Corporation (CNMD) is well poised for growth in the coming quarters, courtesy of its broad product spectrum. The optimism, led by the solid recurring revenue base and potential in General Surgery, is expected to contribute further. However, headwinds from supply-chain constraints and data security threats persist.Shares of this Zacks Rank #3 (Hold) company have lost 3.3% in the past six months against the industry’s 6.5% growth. The S&P 500 Index has increased 14.3% in the same time frame.CONMED, a r ...